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We investigated the stability and mechanisms of loss of foreign gene expression in two recombinant vesicular stomatitis
viruses (VSVs). A recombinant expressing the cellular CD4 protein exhibited remarkable stability of foreign gene expression.
However, after 26 sequential passages, a mutant no longer expressing CD4 was recovered from the virus stock. Sequencing
of the CD4 coding region in this mutant revealed a single nucleotide deletion causing a frameshift and termination of protein
synthesis. A second VSV recombinant expressing the measles virus F protein grew poorly and exhibited extreme instability
of expression of the F protein. Expression of F protein was lost rapidly through mutations of the upstream transcription
termination site from 39AUAC59 to 39AUAU59, as well as lengthening of the subsequent U7 tract that is the template for poly(A)
addition to VSV G mRNA. Such mutations resulted in fusion of the F mRNA to the 39 end of the G mRNA, making the F protein
translation initiation codon inaccessible. We suggest that the VSV polymerase is error prone during replication of the U7 tract,
providing a rapid means for complete elimination of expression of proteins that are toxic to the virus life cycle. © 2001 Academic
Press
e
t
1INTRODUCTION
Vesicular stomatitis virus (VSV) is a nonsegmented,
negative-strand RNA virus of the rhabdovirus family. The
11,161 nucleotide genomic RNA is transcribed into a
47-nucleotide leader RNA and five subgenomic capped
and polyadenylated mRNAs by an RNA-dependent RNA
polymerase (reviewed in Wagner and Rose, 1996). The
mRNAs encode five structural proteins: the nucleocapsid
protein (N), the polymerase complex (P and L), the matrix
protein (M), and the glycoprotein (G).
Following entry, the viral genome is transcribed by the
polymerase starting at the exact 39 end of the genome,
synthesizing the leader RNA and mRNAs sequentially
(Abraham and Banerjee, 1976; Ball and White, 1976).
Sequential transcription is thought to occur by a stop–
start mechanism in which polymerase adds poly(A) to
each mRNA, terminates, and then initiates transcription
of the next gene. Each of the four gene junctions con-
tains a conserved sequence that consists of the tran-
scription stop and polyadenylation signal [39AUAC(U)7
59],
n intergenic dinucleotide (GA or CA) followed by an
nitiation site (39UUGUCNNUAG59) encoding the 59-termi-
al sequence cap-AACAGNNAUC of each mRNA (Rose,
980).
Our laboratory developed the methodology for recov-
1 Present address: Division of Infectious Diseases, Thomas Jefferson
niversity, 329 Jefferson Alumni Hall, 1020 Locust Street, Philadelphia,
A 19107-6799. E-mail: matthias.schnell@mail.tju.edu.2 To whom correspondence and reprint requests should be ad-
dressed. Fax: 203 785-7467. E-mail: john.rose@yale.edu.
427ring VSV from plasmid DNA and for expressing addi-
ional genes from VSV recombinants (Lawson et al.,
995; Schnell et al., 1996a; Kretzschmar et al., 1997). By
inserting the appropriate transcription signals flanking
extra genes into existing 59- or 39-noncoding regions,
new transcription units can be created (Schnell et al.,
1996b; Kretzschmar et al., 1997) and many proteins have
been expressed from such recombinants (Johnson et al.,
1997; Roberts et al., 1998).
Spontaneous mutation rates in RNA viruses are high
because of polymerase errors introduced in the genome
during viral replication (Steinhauer et al., 1989; Bilsel and
Nichol, 1990; Kearney et al., 1993; Drake and Holland,
1999). Although we were concerned initially that such
high mutation rates would rapidly eliminate expression
of extraneous genes, this is generally not the case. In
VSV expressing the bacterial enzyme chloramphenicol
acetyl transferase (CAT), expression of the CAT protein
was stable for at least 15 passages involving one million-
fold amplification with each passage, with relatively few
nucleotide changes (Schnell et al., 1996b). Sequencing of
CAT mRNAs from several cloned viruses after passage
15 revealed only two base changes out of 2400 nucleo-
tides sequenced, and neither of these eliminated protein
expression. The rate of accumulation of mutations in VSV
is consistent with what is seen in other RNA viruses
(Drake and Holland, 1999). Although expression of most
foreign genes in VSV is genetically stable, expression of
at least one gene encoding the measles F protein was
extremely unstable (Schnell et al., 1996a). The F gene
expression apparently inhibits some aspect of VSV
0042-6822/01 $35.00
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428 QUIN˜ONES-KOCHS ET AL.growth, creating a strong selective pressure to eliminate
expression. In this paper we analyzed mutations that
caused rapid elimination of F protein expression from a
VSV recombinant. In addition, we analyzed the mecha-
nism of loss of CD4 expression from a very stable VSV
recombinant.
RESULTS
To analyze the stability of foreign gene expression and
mechanisms of loss of expression, we used one recom-
binant VSV exhibiting very stable expression of a foreign
protein (VSV-CD4) (Schnell et al., 1996a) and a recombi-
nant VSV with highly unstable expression of a foreign
protein (VSV-MF) (Schnell et al., 1996a). VSV-CD4 ex-
resses the cellular protein CD4 and expression is not
ost after extensive passaging (Schnell et al., 1996a). In
ontrast, VSV-MF expresses the measles F protein and
ome loss of expression is observed even in the first
assage after recovery of the virus (Schnell et al., 1996a).
he CD4 and F genes were expressed from the same
osition in the VSV-XN vector between the G and L genes
Fig. 1) (Schnell et al., 1996a).
xpression of the CD4 protein in VSV infected cells
To determine whether any loss of CD4 expression
ould be observed after extensive growth, we grew se-
FIG. 1. Diagram of VSV-CD4 and VSV-MF genomes. VSV-CD4 ex-
resses the cellular protein CD4, while VSV-MF expresses the measles
irus F protein. The enlarged CD4 gene show the primers (arrows) at
heir 59 position used for RT-PCR, which generated two PCR fragments
sed for sequencing. Additional primers within the PCR fragments
ere used for sequencing. The enlarged region in VSV-MF represents
he VSV G 39 coding region and the 59 noncoding region of MF. The
indicated primers were used for RT-PCR and sequencing the G-MF
gene junction. The noncoding regions in the CD4 gene are shown as
hatched boxes.uential low multiplicity passages of virus and examined
ndividual infected cells by immunofluorescence micros-
F
aopy for CD4 expression. By passage 26, we began to
bserve infected cells not expressing CD4. At this point
e isolated individual plaques of virus to determine
hether any showed loss of CD4 expression. Stocks
rown from five plaques were used to infect BHK cells
nd double-label immunofluorescence microscopy was
sed to detect both CD4 and VSV G on the same cells.
wo of the five plaques were found negative for CD4, yet
ositive for VSV G. Examples are shown in Fig. 2 with
ppropriate controls. As expected, recombinant wildtype
rwt) VSV infected cells were positive for VSV G but not
D4. BHK cells infected with first-passage VSV-CD4,
esignated p1, were positive for both VSV G and CD4.
ne of the viral stocks from the twenty-sixth passage of
SV-CD4, designated p26-2, had lost expression of CD4
ut still expressed VSV G. Another viral stock designated
26-3 retained both CD4 and VSV G expression.
To examine the level of CD4 expression, we infected
HK cells with VSV-CD4, labeled cells with [35S]methi-
nine, and immunoprecipitated with anti-CD4 OKT4 MAb
Reinherz et al., 1979). Immunoprecipitates were exam-
ned by SDS–PAGE as shown in Fig. 3. CD4 was detected
n both p1 and p26-3 infections, but not in p26-2 infec-
ions, just as in Fig. 2. The VSV L, N, P, and M proteins
ere visible in the rwt VSV infected lane (not immuno-
recipitated) and also in some of the immunoprecipitates
ecause of nonspecific binding during immunoprecipita-
ions.
NA expression in VSV-CD4-infected cells
To determine whether p26-2 expressed CD4 mRNA,
e performed Northern blots. BHK cells were infected
ith VSV-CD4 viruses. Total RNA was extracted from
ells, separated in an agarose gel, and analyzed by
orthern blot using probes against VSV M and CD4. VSV
mRNA with 200 nucleotides of poly(A) is 1038 nucle-
tides long, and CD4 mRNA with 200 nucleotides of
oly(A) is 2125 nucleotides long. As shown in Fig. 4, a
and with the size expected for VSV M mRNA is present
n VSV-CD4 infections as well as rwt VSV infections when
he M probe was used in the Northern blot. When the
D4 probe was used, a band with the size of CD4 mRNA
as present in all VSV-CD4 infections, but not in rwt VSV
nfections. Expression of CD4 mRNA was at similar lev-
ls in p1, p26-2, and p26-3, suggesting that loss of pro-
ein expression in p26-2 was not related to loss of mRNA
ynthesis.
T-PCR and sequencing the CD4 gene
To determine the mechanism by which p26-2 lost CD4
xpression and to identify possible mutations in p26-3,
e performed RT-PCR of genomic RNA or mRNA and
equenced the entire CD4 coding region. Table 1 and
ig. 1 show the sequence of primers used for RT, PCR,
nd sequencing reactions. Except for one negative-
w
e n of the
p
429MECHANISMS OF LOSS OF FOREIGN GENE EXPRESSIONsense primer used with p26-3, the rest of the primers
used during the RT reactions were of positive sense.
Figure 5 shows a summary of mutations found in both
FIG. 2. Coexpression of VSV G and CD4 in VSV-CD4-infected cells. BH
ere fixed and stained as described under Materials and Methods. Do
xpression of the VSV G or CD4 proteins. The left panels show detectio
rotein (red).p26-2 and p26-3. In p26-3, one point mutation at position
688 in the CD4 gene was found. The mutation changes aglutamine to a glycine. Two mutations were found in
p26-2. One is a frameshift mutation caused by deletion of
a single adenine residue at position 98 in the CD4 coding
were infected with rwt VSV or VSV-CD4 viruses at an m.o.i. of 10. Cells
bel indirect immunofluorescence microscopy was performed to detect
VSV G protein (green) and the right panels show detection of the CD4K cells
uble-lasequence. This frameshift results in appearance of a
stop codon at position 114, which would truncate CD4 to
a
V
p
i
B
4
430 QUIN˜ONES-KOCHS ET AL.only 38 amino acids. In addition a point mutation found at
position 1296 in the CD4 sequence would replace a
histidine with a tyrosine if the protein could be ex-
pressed.
Protein expression of MF in VSV-infected cells
The MF gene in VSV-MF encodes the measles virus F
glycoprotein, which is cleaved from a precursor of 61
kDa (F0) to F1 and F2 proteins of 41 and 20 kDa (Hardwick
nd Bussell, 1978). It has previously been described that
SV-MF virus grows to low titers and that after only three
assages, expression of MF is completely lost, resulting
n a virus that grows to high titers (Schnell et al., 1996a).
From a second passage stock which still expressed
some F protein, we isolated plaques and grew viral
stocks from each. From seven viral stocks prepared from
seven plaques, four were positive and three were nega-
tive for cell surface expression of MF by IF of infected
BHK cells (data not shown). However, it should be noted
that even the F positive clones showed a large fraction of
infected cells that had lost F expression. Figure 6 shows
the results of metabolic labeling VSV-MF infected cells.
BHK cells were infected with one viral stock positive for
MF expression and designated MF-1, and one viral stock
negative for MF expression and designated MF-2. Cells
were labeled with [35S]methionine and lysates were im-
FIG. 3. Immunoprecipitation of CD4 from VSV-CD4-infected cells.
HK cells were infected with the indicated viruses at an m.o.i. of 20 for
h. Proteins were labeled with [35S]methionine for 1 h. Cell lysates
were then immunoprecipitated with anti-CD4 OKT4 mouse MAb and
protein A agarose. Samples were analyzed by SDS–PAGE (10% acryl-
amide) followed by exposure to a PhosphorImager screen (Molecular
Dynamics). Positions of the VSV L, N, P, M proteins, as well as CD4, are
indicated. The lane labeled rwt VSV shows the positions of VSV pro-
teins, not immunoprecipitated.munoprecipitated with anti-F antibodies (Cattaneo and
Rose, 1993). Consistent with the IF experiments, MF-1still expressed the F protein, while MF-2 did not. The F0
precursor was visible above the VSV N and P proteins,
while the F1 protein was located below N and P. The F2
protein was not detected, as reported previously (Schnell
et al., 1996a).
RNA expression in VSV-MF-infected cells
We examined mRNA expression in VSV-MF-infected
cells by performing a Northern blot similar to the one
described before for CD4. In this experiment, probes for
VSV M, VSV G, and MF were used. The results are shown
in Fig. 7. VSV M mRNA was detected at similar levels in
rwt VSV, MF-1, and MF-2 infected cells. When using the F
probe, two bands were observed in the MF-1 infections,
a minor band of approximately 2 kb and one unexpected
band of 3.5 kb. Since the lower band corresponded to the
size expected for F mRNA (2165 nucleotides) and this
band was not detected in MF-2 infection, this band is
likely the F mRNA. The upper band of approximately 3.5
kb was present in both MF-1 and MF-2 infections. When
using the G probe, a band of 3.5 kb was observed in both
MF-1 and MF-2 infections but not in rwt VSV infections.
Also the VSV G mRNA of 1.792 kb was observed at very
high levels in rwt VSV infections and at low levels in
MF-1 infections. In addition, no VSV G mRNA at all was
detected in MF-2 infections. Northern blot from cells
infected with the rest of the stocks from the individual
plaques revealed the same upper band observed in Fig.
7 when using the F probe and the G probe (data not
shown).
The above results led us to propose a mechanism for
the loss of F expression, which is diagrammed in Fig. 7B.
We postulated that a mutation in the G transcription stop
signal occurs frequently and is rapidly selected for be-
cause it fuses the downstream F transcript to the up-
stream G transcript, preventing F protein synthesis. The
longer transcript would contain both VSV G mRNA and F
mRNA sequences and its predicted length would be
3759 nucleotides, consistent with the upper band ob-
served in the blot using both the F and the VSV G probe.
This proposed mechanism would also explain the com-
FIG. 4. Detection of VSV M mRNA and mRNA encoding CD4. Total
RNA from rwt VSV, p1- (lanes 1), p26-2- (lanes 2), and p26-3- (lanes 3)
infected cells was separated by gel electrophoresis and detected by
Northern blotting with VSV M probe (left) or CD4 probe (right). Positions
of molecular size markers (in kilobases) as well as VSV M and CD4
mRNAs are indicated.
r431MECHANISMS OF LOSS OF FOREIGN GENE EXPRESSIONplete absence of VSV G mRNA in MF-2 infection. In this
situation the G protein would be synthesized from the
longer transcript but not the F protein because eukary-
otic ribosomes are not normally able to initiate internally
at AUG codons.
RT-PCR and sequencing the VSV G/MF intergenic
region
To determine whether there was a mutation in the
transcription stop between the VSV G and MF genes, we
performed RT reactions on total RNA extracted from
MF-1 and MF-2 infected cells. As shown in Table 1 and
Fig. 1, we used positive-sense primers, so the template
would be the negative-strand genomic RNA. Following
RT, DNA was amplified by PCR and fragments were
cloned and sequenced because we were not able to
obtain a readable sequence across the intergenic region
from uncloned DNA. The results from two sequenced
clones from MF-1 and MF-2 are shown in Table 2. All
clones exhibited a mutation in the transcription stop
(39AUAC59 to 39AUAU59) that precedes the poly(A) coding
sequence U7. This mutation alone has been found pre-
FIG. 5. Mutations found in the CD4 sequence of passaged VSV-CD4
ecombinants. A diagram of the CD4 mRNA, oriented 59 to 39, is shown.
T
Primers Used in RT, PC
Primer (sequence number)
59 P
59 TCTGTGGGCTCAGGTCCC 39 (26,221)
59 GTAAAACGGGTTACCCAGGACC 39 (24,264)
59 CCAGGTTCACTTCCTGATGCAA 39 (27,707)
59 ACCCAGGAGAAACAATGG 39 (26,223)
59 AGGACCAGAAGGAGGAGG 39 (26,222)
59 GTTGGCAGTCAATCCGAACACTAGC 39 (30,280)
59 GGAGCCCTGATTTCCCAGAATCTTTATC 39 (30,448)
59 CATTCAAGACGCTGCTTCGCAACTTCC 39 (3245)
59 TTAGGGGTGGGGAGTTGAGTG 39 (28,649)
59 GGGACTAGTCATTCAAGACGCTGCTTCGCAACTTCC (30,334)
59 GTAATACGACTCACTATAGGGC 39 (T7)The p26-3 mutation is indicated above and the p26-2 mutations are
shown below.viously to completely prevent termination (Barr et al.,
1997; Schnell et al., 1998). In addition we found a sur-
prising change in the length of the poly(A) coding se-
FIG. 6. Immunoprecipitation of measles F from cells infected with
VSV MF-1 or MF-2 viruses. BHK cells were infected with the indicated
viruses at an m.o.i. of 20 for 4 h. Proteins were labeled with [35S]me-
thionine for 1 h. Cell lysates were then immunoprecipitated with anti-F
polyclonal antibodies and protein A agarose. Samples were analyzed
by SDS–PAGE (10% acrylamide) followed by exposure to a Phospho-
rImager screen (Molecular Dynamics). Some N and M proteins are
Sequencing Reactions
osition in pVSV-CD4
V-MF sequence Reaction
54281 RT p1, p26-2. PCR p1, p26-2, p26-3. Seq. p1,
p26-2, p26-3.
62681 RT p1, p26-2, p26-3. PCR p1, p26-2, p26-3.
Seq. p1, p26-2, p26-3.
64242 RT p26-3. PCR p1, p26-2, p26-3. Seq. p1.
69852 PCR p1, p26-2, p26-3. Seq. p1, p26-2 p26-3.
58331 Seq. p1, p26-2, p26-3.
58652 Seq. p26-2, p26-3.
56822 Seq. p26-2.
50421 RT MF-1, MF-2, PCR pVSV-MF. Seq. pVSV-MF.
54372 PCR pVSV-MF, MF-1, MF-2. Seq. pVSV-MF.
50421 PCR MF-1, MF-2
N/A Seq. pBS-MF/G.ABLE 1
R, and
rimer p
or pVSalways present in immunoprecipitations due to nonspecific precipita-
tion and their positions are indicated.
432 QUIN˜ONES-KOCHS ET AL.quence from U7 to U8, U9, U12, and U15. Heterogeneity in
the length of this sequence could explain the difficulty in
sequencing directly through this junction. To eliminate
the possibility that the original plasmid used to recover
VSV-MF virus carried a mutation in the VSV G/MF tran-
scription stop, we sequenced the full-length VSV-MF
plasmid used for the viral recovery. As shown in Table 2,
the DNA sequence contains the correct transcription
stop. No mutations were found in the entire sequence of
the MF gene by RT-PCR and sequencing MF-1 and MF-2
(data not shown). These results are consistent with the
Northern blot results and confirm the proposed mecha-
nism for the loss of MF protein expression by mutations
in the transcription stop signal between the VSV G and
MF genes.
DISCUSSION
The results presented in this paper elucidate two
mechanisms involved in loss of foreign protein expres-
sion in recombinant VSVs. We investigated two rVSVs
with opposite patterns of loss of protein expression.
VSV-CD4 did not begin to lose expression of CD4 until
passage 26, while VSV-MF showed loss of measles virus
F protein even in the first passage. Interestingly, the
mechanism of loss of gene expression was different in
each case. In VSV-CD4, a frameshift mutation caused
premature translation termination in the CD4 gene. In
FIG. 7. Northern blot of VSV M and G mRNAs and mRNA encoding
MF. (A) Total RNA from cells infected with rwt VSV, MF-1- (lanes 1), and
MF-2- (lanes 2) infected cells were separated by gel electrophoresis
and detected by Northern blotting with VSV M probe (left), F probe
(middle), or VSV G probe (right). Positions of molecular size markers (in
kilobases) as well as VSV M, G, and F (also shown by arrow) mRNAs
are indicated. (B) Diagram of the VSV G and MF genes in the VSV
genome and model for the generation of the large mRNA containing G
and F. Cap structures are represented by “C” and the poly(A) tail is
represented by “;”.contrast, mutations in the transcription stop sequence
upstream of the F mRNA coding sequence fused the GmRNA sequence to F, eliminating all F protein expres-
sion.
VSV-CD4 viruses grew to normal titers, suggesting that
CD4 expression did not exert a large burden on VSV
replication. Under these circumstances, there is little
selection to eliminate the CD4 gene expression, which
can account for the stability of CD4 even after extensive
passaging of VSV-CD4 viruses. However, since CD4 is
not required for VSV growth, a gradual accumulation of
point mutations would be expected in the gene. CD4
protein expression without loss of the mRNA could be
eliminated directly either by mutation of any codon to a
stop codon, or by frameshift generating a stop codon.
There is presumably a small growth advantage to the
virus not encoding CD4, leading to accumulation of the
CD4-negative frameshift mutant in the culture by pas-
sage 26.
The remarkable instability of measles F protein ex-
pression was reported previously (Schnell et al., 1996a),
but the mechanism of this rapid loss of expression was
not understood. It is likely that the F protein is in some
way toxic to VSV growth. Recombinant VSVs expressing
the F protein were very difficult to recover and initially
grew to titers 3 logs below rwt VSV. Passaging led to
complete loss of F expression by passage three, and the
virus then grew to rwt titers. Measles F is a type I
membrane protein with a hydrophobic C-terminal mem-
brane anchor sequence. We do not know why F gene
expression is so toxic to VSV replication, but a similar
effect has been observed in vaccinia recombinants (Stit-
telaar et al., 2000). Recombinants expressing low levels
of F protein can be made, but high levels of protein
expression are apparently toxic to vaccinia replication. It
is possible that the F protein interferes with VSV G
protein trafficking or virus assembly, but this is difficult to
study with such an unstable mutant. Because indepen-
dent plaques that were initially positive for measles F
protein expression showed rapid selection of fused
mRNAs, it appears that mutation of the upstream tran-
scription stop sequence is the preferred mechanism to
eliminate F protein expression. Our results suggest that
the transcription stop sequence may be a hotspot for
mutation since there are so many other sites in F where
a point mutation could eliminate F protein synthesis.
The transcription stop mutation was selected rapidly
TABLE 2
RNA Sequence of the G/F Transcription Stop in VSV-MF Viruses
Plasmid or virus Sequence
pVSV-MF AUAC(UUUUUUU)7
MF-1, clone 1 AUAU(UUUUUUUU)8
MF-1, clone 2 AUAU(UUUUUUUUUUUU)12
MF-2, clone 1 AUAU(UUUUUUUUUUUUUUU)15
MF-2, clone 2 AUAU(UUUUUUUUU)9
t
b
m
m
t
c
d
f
(
433MECHANISMS OF LOSS OF FOREIGN GENE EXPRESSIONand repeatedly for VSV-MF; however it was not observed
for VSV-CD4. It is possible that there is no significant
pressure against CD4 protein expression and that we
only see a gradual accumulation of mutations that are
not selected. If we did additional passaging of VSV-CD4
viruses, we might find some that lose expression by
mutation of the upstream transcription stop. However,
there could also be a selection against the transcription
stop mutation because it adds a large 39 untranslated
sequence to the G mRNA and might decrease mRNA
stability and G synthesis. This model could explain the
rapid selection of the transcription stop mutation only for
VSV-MF when virus replication is severely compromised
by the foreign protein expression. Similar mutations in
VSV-CD4 are presumably occurring but might be se-
lected against and thus not emerge as CD4 negative
virus clones.
The formation of bicistronic mRNA as a mechanism to
inhibit expression of the measles F protein has been
observed in measles virus itself (Hummel et al., 1994). A
hamster neurotropic strain of measles virus passaged in
Vero cells resulted in a persistently infected cell line
(HNT-PI) and viruses defective for syncytia formation and
extracellular release. These defects were in part caused
by the absence of expression of the F protein as a result
of the predominance of M/F readthrough transcripts in
infected cells.
There are two possible scenarios that might explain
how mutations in the transcription stop signal were in-
troduced by the VSV RNA polymerase, during negative-
strand or positive-strand replication. In the process of
synthesizing the positive strand during replication, a
polymerase might replicate the G gene end-sequence
GA7 to A8–A15, mutating the critical G residue to A. We
prefer the alternative model that the mutation occurred
during synthesis of the minus strand with the polymerase
mutating the U7C sequence to U8–U15, including mutating
he critical C to a U. In this model the polymerase would
e a particularly error-prone state when copying ho-
opolymeric sequences, both lengthening the ho-
opolymeric sequence and making a base substitution
emplated by the preceding nucleotide. This situation
ould be related to the normal ability of the polymerase
uring transcription to copy the U7 sequence to generate
A150–200. Also, other polymerases are known to be error
prone within and at the ends of homopolymeric se-
quences, supporting our proposal that the mutation oc-
curred during synthesis of the genomic RNA. For exam-
ple, the reverse transcriptase of the type 1 human immu-
nodeficiency virus is known to be error prone for single-
nucleotide substitution, addition, and deletion within and
at the ends of homopolymeric sequences (Bebenek et
al., 1993). Of particular relevance, it was shown that base
substitution errors could be templated by the preceding
nucleotide.
Selection of a VSV revertant through mutations in the
g
ftranscription stop was observed previously (Schnell et
al., 1998). In that case, a mutant called VSV-CT1 that
contained only one amino acid in the cytoplasmic tail of
G was studied. It grew slowly but a fast growing revertant
was selected after 19 passages. The revertant had two
mutations, one similar to the transcription termination
mutants described here (UAUGA7 mutated to UAUA8) that
eliminated the transcription stop and a second mutation
that eliminated the translation stop, resulting in a gain of
eight amino acids by translational readthrough into the
extended transcript. If the mutation in the transcription
stop is a relatively frequent event as suggested by our
data, it is easier to understand how such a double
mutant might have been selected at a relatively low
passage number.
Mutational analysis of the sequences involved in the
termination of transcription in VSV have also demon-
strated that alteration in any nucleotide of the AUACU7
sequence can decrease termination activity and result in
the synthesis of readthrough mRNA (Barr et al., 1997).
Interestingly, changes in the C are most critical and
completely inhibit mRNA termination. Alteration of the
poly(U) from 7 to 14 residues had no dramatic effect on
the termination of an upstream gene, but did influence
initiation of the downstream mRNA synthesis. From
these data it seems that it was the nucleotide substitu-
tion G to A in the tetranucleotide and not the extension in
the poly(U) tract that caused inhibition of termination of
VSV G RNA, resulting in the VSV G/MF transcript ob-
served in the Northern blot.
In addition to defining mechanisms of loss of gene
expression, our studies confirm earlier studies (Schnell
et al., 1996a,b), showing that VSV can be used as high
level, stable expression vectors for foreign proteins such
as CD4 that do not interfere with VSV replication. The
high rate of polymerase errors introduced by the VSV
RNA polymerase does not compromise the expression of
foreign proteins unless there is a strong selection
against maintenance of foreign protein expression. Re-
markable stability of a foreign gene expressed in another
negative-strand virus has been reported (Singh and Bil-
leter, 1999). Thus, many of the nonsegmented negative-
strand RNA viruses may prove useful as stable gene
expression vectors.
MATERIALS AND METHODS
Passaging of VSV-CD4 and VSV-MF viruses
Low-multiplicity virus passaging was previously de-
scribed (Schnell et al., 1996b). Approximately 105 plaque
orming units (PFUs) of VSV-CD4 or VSV-MF viruses
Schnell et al., 1996a) obtained from single recoveries
were added to 107 baby hamster kidney (BHK) cells and
rown for 18 h at 37°C. This process was repeated once
or VSV-MF and 25 times for VSV-CD4.
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434 QUIN˜ONES-KOCHS ET AL.Immunofluorescence (IF) microscopy
BHK cells on 3.5-cm-diameter plates were infected for
4 h with VSV-CD4 viruses or VSV-MF viruses. To test CD4
and VSV G expression, cells were fixed using a mild
fixation procedure modified from the McLean and Na-
kane (1974) fixation. The fixative was prepared by com-
bining 6 ml H2O with 6 ml 100 mM Na2HPO4 (pH 7.8)
containing 220 mg lysine. NaIO4 (30 mg) was added to
his solution and vortexed thoroughly before the addition
f a solution containing 3.66 ml 8% paraformaldehyde
nd 8 mM NaOH. Cells were incubated in fixative for
.5 h. Following fixation, cells were washed twice with
BS plus 10 mM glycine (PBS-G). Cells were then incu-
ated with either OKT4 mouse monoclonal antibody
MAb) against CD4 (Reinherz et al., 1979) or a rabbit
olyclonal antibody to VSV. The secondary antibodies
ere Texas Red-conjugated goat anti-mouse (Jackson
mmunoresearch) and fluorescein isothiocyanate (FITC)-
onjugated goat anti-rabbit antibodies (Jackson Immu-
oresearch).
For MF and VSV G expression, cells were fixed with 3%
araformaldehyde and permeabilized with 1% Triton
-100 (in PBS-G). Cells were then stained with polyclonal
abbit antibodies against measles F (Cattaneo and Rose,
993) and I1 anti-VSV G mouse MAb (Lefrancois and
yles, 1982), followed by FITC-conjugated goat anti-rab-
it (Jackson Immunoresearch) and Texas Red-conju-
ated goat anti-mouse antibodies (Jackson Immunore-
earch), respectively. Cells were visualized using a Ni-
on Microphot FX microscope equipped with
pifluorescence and a 403 planapochromat objective.
hotographs were taken with a Spot CCD camera.
etabolic labeling of infected cells
Approximately 5 3 105 BHK cells on 35-mm-diameter
lates were infected in 0.5 DMEM for 0.5 h with rwt or
VSVs at an m.o.i. of 20. DMEM supplemented with 10%
etal bovine serum (FBS) (1.5 ml) was added to the plates
or 4 h at 37°C. Cells were then washed with methionine-
ree medium and labeled with 100 mCi of [35S]methionine.
fter 1 h, cells were washed with PBS and lysed with 0.5
l of detergent solution [1% Nonidet P-40 (NP-40), 0.4%
eoxycholate, 50 mM Tris–HCl (pH 8), 62.5 mM EDTA]
ontaining 5 U aprotinin. Lysates were transferred to
.5-ml Eppendorf tubes and centrifuged in an Eppendorf
icrofuge at 10,000 rpm for 2 min to remove nuclei. The
upernatants were transferred to new tubes, and SDS
as added to a final concentration of 0.2%.
mmunoprecipitation of infected cell lysates
Immunoprecipitations were performed by adding 2 ml
KT4 mouse anti-CD4 MAb (Reinherz et al., 1979) or 2 ml
olyclonal rabbit antibodies against measles F (Schnell
t al., 1996a) to the cell lysates and incubating for 0.5 ht 37°C. Samples were then incubated with 40 ml of
Protein A agarose for 15 min, pelleted, washed three
times with ice-cold radioimmunoprecipitation assay
buffer (RIPA) [0.1% SDS, 1% deoxycholate, 1% NP-40, and
0.15 M NaCl in 10 mM Tris (pH 7.4)], and resuspended in
40 ml of 13 sample buffer. About 20 ml of each sample
was loaded and analyzed by sodium dodecyl sulfate
(SDS), 10% polyacrylamide gel electrophoresis (PAGE),
followed by exposure to a PhosphorImager screen (Mo-
lecular Dynamics).
Preparation of probes for Northern blot hybridization
Probes were derived from plasmid inserts encoding
the CD4, MF, M, and G proteins. All DNA fragments were
separated in a 10% agarose gel and the fragments to be
used as probes were excised from the gels and purified
by Gene-Clean kit (Bio 101). DNA concentration of all
fragments was determined by optical density readings at
260 nm. Approximately 100 ng of each DNA fragment and
50 ng of l DNA marker (New England Biolabs) were then
incubated with Klenow Fragment (39–59Exo) kit (New
England Biolabs) and 30 mCi [32P]dCTP in a total volume
of 50 ml.
orthern blot
Approximately 2 3 106 BHK cells on 10-cm-diameter
plates were infected with VSV-CD4 or VSV-MF viruses at
an m.o.i. of 5 for 4 h. RNA from infected cells was isolated
using the RNeasy kit (Qiagen). One microgram of RNA
was loaded and fractionated in a 1% agarose gel con-
taining 38% formaldehyde and 13 phosphate buffer. RNA
from the gel was then transferred to a nitrocellulose
membrane for 18 h in 203 SSC (3 M NaCl, 0.3 M
C6H5Na3O7 p 2H2O, pH 7.0). The membrane was
rosslinked using an UV Stratalinker 1800 (Stratagene) in
uto cross-link setting of 1200 mJ for 50 s. After drying the
embrane in a vacuum/oven (Precision) for 0.5 h, it was
rewashed in an oven/rotator (Bellco) at 65°C for 0.5 h
sing hybridization buffer (1 mM EDTA, 7% SDS, 0.25 M
a2HPO4, pH 7.2). The membrane was hybridized for 18 h
with approximately 106 counts per minute (cpm) of probe
esuspended in 5 ml hybridization buffer at 65°C in the
ven/rotator. The membrane was then washed at 60°C
or 0.5 h using a 5% wash buffer (5% SDS, 1 mM EDTA, 20
M Na2HPO4, 20 mM NaH2PO4, pH 6.9), followed by two
washes using wash buffer. Finally, the membrane was
dried for 20 min and exposed to a Molecular Dynamics
PhosphorImager screen.
Reverse transcription (RT)-PCR and DNA sequencing
BHK cells on 6.5-cm-diameter plates and 70% conflu-
ent were infected with recombinant viruses for 4 h at an
m.o.i. of 20. Total RNA was isolated from infected cells
using the RNeasy kit (Qiagen). RT reactions were per-
formed with approximately 0.8 mg RNA and Superscript II
p
a
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r
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f
u
w
g
l
g
t
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435MECHANISMS OF LOSS OF FOREIGN GENE EXPRESSIONreverse transcriptase kit (Gibco-BRL) in a final volume of
12 ml. PCR reactions were performed using 1–5 ml RT
roduct, 300 mM of each dNTP, 600 nM of each primer,
nd 0.5 ml Vent polymerase (New England Biolabs) in a
inal volume of 50 ml. Purified PCR products were se-
uenced by the Yale W. M. Keck Foundation Biotechnol-
gy Resource Lab DNA Sequencing Group. Table 1 and
ig. 1 show primers used in RT, PCR, and sequencing
eactions. In the case of the viral stock MF-1 and MF-2
escribed in the results, following RT, PCR was per-
ormed using a primer containing a SpeI site (SpeI site
nderlined in Table 1). PCR products were then digested
ith SpeI and ClaI (ClaI site located upstream the MF
ene) restriction enzymes (New England Biolabs), fol-
owed by cloning into pBS (Stratagene) previously di-
ested with SpeI and ClaI. Purified plasmids containing
he MF-1 or MF-2 insert were then sequenced.
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